中文


2009-5-12
National Research Centre of Antibody Drugs Settles in Zhangjiang
2009-3-6
Shen Investigates CPGJ
2009-1-16
Continuous Innovation, Developing Together
2008-12-17
Li Visits CPGJ
2008-11-26
Delegation from Yunnan Province Visit CPGJ


What's monoclonal antibody (mAB)?
monoclonal antibody (mAB) ?A single type of antibody that is directed against a specific epitope (antigen, antigenic determinant) and is produced by a single clone of B cells or a single hybridoma cell line, which is formed by the fusion of a lymphocyte cell with a myeloma cell. Some myeloma cells synthesize single antibodies naturally.

 




CPGJ is Focusing on biopharmaceutical products development,manufacturing,
and marketing,in china and in the world.

CPGJ targets on producing therapeutic humanized/human antibodies,vaccines,and diagnostic products for unmet medical needs,in cancer and autoimmune diseases.



 
  Yisaipu

DESCRIPTION
Proprietary Name:  Recombinant Human Necrosis Factor-αReceptorII:IgG Fc (rhTNFR:Fc) Fusion Protein for Injection
Brand Name:   Yisaipu
Composi



No.399 Libing Road,Zhangjiang Hi-tech Park,
Shanghai 201203,P.R.China
Tel : 86-021-50791399
Fax:86-021-58553335


  Copyright 2002-2006 Shanghai CP Guojian Pharmaceutical Co.,Ltd.